Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
NioCorp prices $100 million public offering at $5 per share
-
NioCorp Announces Pricing of $100.0 Million Public Offering of Common Shares
-
Maxim Group Starts Scienture Holdings (SCNX) at Buy
-
Blue Hat Interactive prices $6.4 million public offering at $0.20 per unit
-
Blue Hat Interactive Entertainment Technology Announces Pricing of US$6.4 Million Public Offering
-
20/20 BioLabs begins trading on NASDAQ under ticker AIDX
-
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
-
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
-
Maxim Group Starts Evaxion Biotech (EVAX) at Buy
-
HCW Biologics prices $1.5 million follow-on offering at $0.6055 per unit
-
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
-
Ethema Health Corporation Partners With B2i Digital as Featured Company to Expand Investor Awareness
-
VerifyMe and Open World sign merger agreement
-
Liminatus Pharma prices $4 million public offering at $0.29 per share
-
Liminatus Pharma prices $4 million public offering at $0.29 per share
-
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
-
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
-
XFLH Capital completes $100 million initial public offering on NYSE
-
XFLH CAPITAL CORPORATION ANNOUNCES CLOSING OF $100 MILLION INITIAL PUBLIC OFFERING
-
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
-
Jupiter Neurosciences Selected as B2i Digital Featured Company
-
Braiin Ltd. to Commence Trading on the Nasdaq Global Market Under the Symbol "BRAI"
-
VerifyMe and Open World announce merger agreement
-
VerifyMe and Open World sign merger to create tokenization platform
-
Open World and VerifyMe Sign Merger Agreement
-
Open World and VerifyMe Sign Definitive Merger Agreement
-
Open World and VerifyMe Sign Merger Agreement
-
XFLH Capital prices $100 million IPO at $10 per unit
-
XFLH CAPITAL CORPORATION ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
-
MDJM completes $6 million public offering
-
MDJM LTD Announces Closing of Upsized $6.0 Million Public Offering
-
SeaStar Medical Holding Corp. (ICU) PT Lowered to $6 at Maxim Group
-
AIM ImmunoTech Announces Commencement of Rights Offering
-
MDJM prices upsized $6 million public offering at $1.40 per unit
-
MDJM LTD Announces Pricing of Upsized $6.0 Million Public Offering
-
Maxim Group Upgrades INVO Fertility (IVF) to Buy
-
Bond Debuts on NASDAQ: Ushering in a New Era of AI-Powered Preventative Personal Security
-
Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing
-
Maxim Group Downgrades Allbirds Inc (BIRD) to Hold
-
Elong Power closes $7.6 million public offering
-
Elong Power Holding Limited Announces Closing of US$7.6 Million Public Offering
-
Bond to Go Public on Nasdaq as Catalyst for Global Scale
-
Elong Power prices $7.6 million public offering at $3.16 per unit
-
Elong Power Holding Limited Announces Pricing of US$7.6 Million Public Offering
-
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
-
Maxim Group Starts Cadiz Inc (CDZI) at Buy
-
Maxim Group Starts InspireMD (NSPR) at Buy
-
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)
-
Maxim Group Downgrades Quince Therapeutics Inc. (QNCX) to Hold
-
Saratoga Investment prices $100 million bond offering at 7.50%

